Abstract P1160: Gut Microbiota, Circulating Inflammatory Markers, and Cardiac Dysfunction In Women Living With HIV

Z Zheng Wang S Sanyog Shitole (UCSF, San Francisco, California, United States) A Anjali Sharma D David Hanna B Brandilyn Peters-Samuelson (Albert Einstein College of Medicine, Bronx, New York, United States) T Tao Wang W Wendy Post (JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States) A Alan Landay K kathleen weber (Hektoen Institute of Medicine, Chicago, Illinois, United States) A Audrey French (Stroger Hospital of Cook County, Chicago, Illinois, United States) D Daniel Merenstein S Sabina Haberlen (Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States) A Alan Hinderliter (University of North Carolina, Chapel Hill, North Carolina, United States) I Igho Ofotokun C Claudia Martinez J Julie Schexnayder (The University of Alabama at Birmingham, Birmingham, Alabama, United States) J Jason Lazar (SUNY Downstate, Brooklyn, New York, United States) D Deborah Gustafson K Kathryn Anastos R Rob Knight (Department of Pediatrics) R Robert Kaplan R Robert Burk (Albert Einstein College of Medicine, Bronx, New York, United States) J JORGE KIZER (Univ California San Francisco, Kentfield, California, United States) Q Qibin Qi

Abstract

Introduction: The relationships among gut microbial alterations, host inflammation, and cardiac dysfunction remain understudied, particularly in the context of HIV. Hypothesis: We hypothesized that higher abundance of pro-inflammatory gut bacteria is associated with higher levels of host circulating inflammatory makers and cardiac dysfunction. Methods: We examined associations of gut microbial features (16S rRNA sequencing) with cardiac dysfunction (Echocardiography) in 973 women from the MACS/WIHS Combined Cohort Study. Cardiac dysfunction was defined as the presence of left ventricular systolic (LV ejection fraction<54%) or diastolic (ASE 2016 criteria) dysfunction. In a subset (n=397), we further integrated cardiac dysfunction-associated microbial features (Shotgun metagenomics sequencing) with serum proteomic inflammatory markers (Olink platform inflammation panel) in relation to cardiac dysfunction. Results: The potentially pathogenic bacteria Streptococcus, Eggerthella and Anaeroglobus , were positively associated with cardiac dysfunction, while the beneficial genera Roseburia and Alistipes were linked to lower odds of cardiac dysfunction ( Fig. 1A ). Results were consistent in women with and without HIV. These cardiac dysfunction-associated bacteria were associated with a number of circulating proteomic inflammatory markers ( Fig. 1B ). For example, the pathogenic Streptococcus was positively associated with the pro-inflammatory cytokines IL-8 and IL-6, the chemokine MCP-3 (linked to immune response and atherosclerosis), and the inflammatory mediator OSM (associated with vascular inflammation and heart failure). Proteomic inflammatory scores were generated for each genus based on their specific inflammatory marker profiles. The inflammatory score for Streptococcus was significantly associated with cardiac dysfunction ( Fig. 1C ). Associations between bacterial genera and cardiac dysfunction were attenuated after further adjustment for specific microbial associated inflammatory markers ( Fig. 1D ). Conclusion: Among women living with or at risk of HIV, we identified gut microbial features associated with cardiac dysfunction, with certain microbiota-related inflammatory markers partially explaining these associations.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue Suppl_1
Published March 11, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (24)

Z

Zheng Wang

S

Sanyog Shitole

UCSF, San Francisco, California, United States

A

Anjali Sharma

D

David Hanna

B

Brandilyn Peters-Samuelson

Albert Einstein College of Medicine, Bronx, New York, United States

T

Tao Wang

W

Wendy Post

JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States

A

Alan Landay

K

kathleen weber

Hektoen Institute of Medicine, Chicago, Illinois, United States

A

Audrey French

Stroger Hospital of Cook County, Chicago, Illinois, United States

D

Daniel Merenstein

S

Sabina Haberlen

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States

A

Alan Hinderliter

University of North Carolina, Chapel Hill, North Carolina, United States

I

Igho Ofotokun

C

Claudia Martinez

J

Julie Schexnayder

The University of Alabama at Birmingham, Birmingham, Alabama, United States

J

Jason Lazar

SUNY Downstate, Brooklyn, New York, United States

D

Deborah Gustafson

K

Kathryn Anastos

R

Rob Knight

Department of Pediatrics

R

Robert Kaplan

R

Robert Burk

Albert Einstein College of Medicine, Bronx, New York, United States

J

JORGE KIZER

Univ California San Francisco, Kentfield, California, United States

Q

Qibin Qi